Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Green Peptide Looks to Rejuvenate iPS-Derived T Cells

Filed Under: Innovation, Pharma Tagged With: , , ,

Having acquired Advanced Immunotherapy Co. Ltd. (AIT) as a subsidiary in December 2016, Green Peptide Co. Ltd. (TYO:4594) is now…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Tokyo Tech Works on New Form of Photodynamic Cancer Treatment
Tokyo Tech Works on New Form of Photodynamic Cancer…
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Tokyo Institute of Technology, Kanto Chemical Develop Growth…
Asahi Kasei Turns Focus to Next-Gen Technologies
Asahi Kasei Turns Focus to Next-Gen Technologies
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Asahi Kasei Joins Germany’s SAP to Create Optimization System for Green Hydrogen Production
Asahi Kasei Joins Germany’s SAP to Create Optimization…